Escitalopram-induced epistaxis: A case report
| Autor: | Sumayah Aljhani |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Pediatrics
medicine.medical_specialty Cirrhosis Case Report التهاب الأنف التحسسي مثبطات امتصاص السيروتونين الانتقائية Allergic rhinitis رعاف Escitalopram Selective serotonin reuptake inhibitors mental disorders medicine In patient Platelet activation Adverse effect Depression (differential diagnoses) إسيتالوبرام business.industry Bleeding نزيف General Medicine medicine.disease Epistaxis Seasonal allergy Anxiety medicine.symptom business medicine.drug |
| Zdroj: | Journal of Taibah University Medical Sciences |
| ISSN: | 1658-3612 |
| DOI: | 10.1016/j.jtumed.2021.06.004 |
| Popis: | Selective serotonin reuptake inhibitors (SSRIs) are a group of drugs used to treat various psychiatric disorders such as major depression, generalised anxiety, and obsessive-compulsive syndrome. Although generally safe, SSRIs can lead to various adverse effects, including an increased risk of bleeding due to their effect on platelet activation and aggregation. Unexpected bleeding can occur at different sites, in people of different age groups, and in combination with other medications. The commonly reported risk factors associated with medication-induced bleeding in patients with mental disorders include co-administration of other drugs and liver cirrhosis or failure. We report a relatively less common adverse effect of SSRIs. This is the case of a Middle Eastern man, known to have seasonal allergic rhinitis, who developed self-limiting epistaxis following the use of escitalopram for a depressive disorder. Since a history of seasonal allergy can precipitate bleeding when using SSRIs, risk factors for bleeding associated with SSRIs, excluding the common causes, should be explored for better management and prevention. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|